As noted by the Alzheimers Drug Discovery Foundation (ADDF), the bulk of research involving epithalamin and epithalon has been conducted in Russia (or formerly, the Soviet Union) and has not been subject to independent confirmation [1]
These brand-name medications have undergone rigorous testing in clinical trials to review their safety, efficacy, and purity
Hormone Replacement Therapy (HRT): The Stepwise Method Instead of jumping into full hormone replacement, McCall recommends a phased approach: Prioritize Based on Symptoms: Progesterone: For anxiety, insomnia, heavy periods, mood swings Testosterone: For low libido, energy issues, muscle loss Estrogen: Last to drop, often during peri/menopause Action Plan: Begin with the hormone causing the most distress
AMYRs are heterodimers of the class B1 G protein-coupled receptor, calcitonin (CT) receptor (CTR), and receptor activity-modifying proteins (RAMPs) 6,7
Routine supplementation with biotin is not recommended , as evidence for its benefit in telogen effluvium is limited, and high-dose biotin can interfere with certain laboratory tests (including thyroid function tests and troponin assays), potentially producing misleading results an issue highlighted in MHRA Drug Safety Update guidance
GLP-1 drug usage was associated with a reduced risk of just about everything bad: substance use and psychotic disorders, seizures, neuro-cognitive disorders (including Alzheimers disease and dementia), coagulation disorders [e.g., means clotting], cardio-metabolic disorders, infectious illnesses and several respiratory conditions. When I initially read this study in January, it seemed too good to be true